M&T Bank Corp Grows Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

M&T Bank Corp grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,952 shares of the company’s stock after buying an additional 218 shares during the quarter. M&T Bank Corp’s holdings in HCA Healthcare were worth $3,587,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Janney Montgomery Scott LLC lifted its position in shares of HCA Healthcare by 18.1% during the third quarter. Janney Montgomery Scott LLC now owns 18,087 shares of the company’s stock worth $7,351,000 after purchasing an additional 2,766 shares in the last quarter. Van ECK Associates Corp acquired a new position in shares of HCA Healthcare during the third quarter worth $752,000. Concurrent Investment Advisors LLC lifted its position in shares of HCA Healthcare by 26.2% during the third quarter. Concurrent Investment Advisors LLC now owns 2,703 shares of the company’s stock worth $1,099,000 after purchasing an additional 561 shares in the last quarter. Summit Global Investments lifted its position in shares of HCA Healthcare by 2.8% during the third quarter. Summit Global Investments now owns 3,287 shares of the company’s stock worth $1,336,000 after purchasing an additional 88 shares in the last quarter. Finally, AIA Group Ltd raised its holdings in HCA Healthcare by 5.3% in the third quarter. AIA Group Ltd now owns 2,000 shares of the company’s stock valued at $813,000 after acquiring an additional 100 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Stock Up 2.6 %

HCA Healthcare stock opened at $330.11 on Friday. The company has a 50-day simple moving average of $316.70 and a 200-day simple moving average of $347.49. The firm has a market capitalization of $81.27 billion, a P/E ratio of 15.03, a P/E/G ratio of 1.10 and a beta of 1.68. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the firm posted $5.90 earnings per share. As a group, equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.87%. The ex-dividend date of this dividend is Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is currently 13.11%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on HCA. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. Barclays lowered their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research note on Monday, January 27th. Finally, Truist Financial lowered their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.